2025-05-30 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the data you provided.

## Natera Inc. (NTRA) Analysis

**Company Overview:** Natera Inc. is a diagnostics company focused on cell-free DNA testing for reproductive health, oncology, and organ health.

### 1. Performance vs. S&P 500 (VOO)

*   **Ticker:** NTRA
*   **Cumulative Return:** 125.66%
*   **VOO Cumulative Return:** 78.87%
*   **Absolute Difference:** 46.8%
*   **Relative Difference:** 13.0%

**Analysis:** NTRA has significantly outperformed the S&P 500 based on cumulative returns. However, the Relative Difference (13%) suggests that while currently positive, NTRA's outperformance is relatively closer to its historical low compared to its high.  This means while the stock is beating the market, its degree of outperformance is not as high as it has been in the past.

**Alpha/Beta Analysis:**

| Year        | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
| ----------- | ------- | ----- | ------- | ----- | ------ |
| 2015-2017   | -6.0%   | 62.4% | -32.0%  | -0.1  | 1.2    |
| 2016-2018   | 29.0%   | 80.1% | 13.0%   | 0.0   | 1.9    |
| 2017-2019   | 159.0%  | 80.1% | 132.0%  | 0.9   | 4.7    |
| 2018-2020   | 530.0%  | 80.1% | 506.0%  | 0.5   | 13.9   |
| 2019-2021   | 356.0%  | 62.9% | 303.0%  | 0.2   | 13.0   |
| 2020-2022   | -119.0% | 62.9% | -124.0% | 0.2   | 5.6    |
| 2021-2023   | -482.0% | 69.9% | -498.0% | 1.2   | 8.7    |
| 2022-2024   | -75.0%  | 70.5% | -91.0%  | 1.2   | 22.1   |
| 2023-2025   | 74.0%   | 72.8% | 45.0%   | 0.8   | 22.0   |

**Analysis:**

*   **CAGR:**  Shows very high volatility in annual returns, from extreme growth periods (e.g., 2018-2020) to significant declines (e.g., 2021-2023).
*   **MDD:**  Consistently high Maximum Drawdown indicates significant risk and volatility.
*   **Alpha:** The Alpha values, while fluctuating, indicate periods of significant outperformance (positive Alpha) and underperformance (negative Alpha) relative to the market. The high positive Alpha in some periods (e.g., 2018-2020) suggests the stock benefited from company-specific factors beyond market trends.
*   **Beta:** Beta values vary. High beta indicates more volatility than the market, while lower indicates less volatility.
*   **Cap(B):** The market capitalization has seen significant fluctuation over the years.

### 2. Recent Price Action

*   **Closing Price:** $158.05
*   **Previous Close:** $161.21
*   **Change:** -$1.96
*   **5-day Moving Average:** 156.44
*   **20-day Moving Average:** 154.98
*   **60-day Moving Average:** 149.13

**Analysis:**  The recent price decrease of $1.96 suggests a slight downward trend.  The closing price is above all three moving averages, which could be seen as a mildly bullish signal.  However, the price closing lower than the previous day suggests the beginning of a short-term downward trend.

### 3. Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.37 (Low Risk)
*   **RSI:** 45.05 (Neutral)
*   **PPO:** 0.23 (Neutral)
*   **Hybrid Signal:** cash_3%_Buy 80% of cash (191 shares - Caution - MRI:0.37)
*   **Recent (20-day) Relative Divergence Change:** -0.3 (Negative - Short-term Decline)
*   **Expected Return:** 151.1% (Long-term, vs. S&P 500)

**Analysis:**

*   **MRI:** Suggests a low-risk environment.
*   **RSI:** The RSI is neutral, indicating neither overbought nor oversold conditions.
*   **PPO:**  The PPO also suggests a neutral trend.
*   **Hybrid Signal:** The signal suggests a cautious approach, advising to buy 80% of cash available for investment with a 3% cash reserve.
*   **Relative Divergence:** The negative change in relative divergence indicates a short-term decline in performance relative to the S&P 500.
*   **Expected Return:** A very high expected return (151.1%) suggests significant potential for long-term outperformance, but this should be viewed cautiously given the historical volatility of the stock.
*   **Price Change:** The price change reflects a slight downward trend.

### 4. Recent News & Significant Events

*   **[2025-05-28]** -  Major business developments, regulatory changes, or market events.
*   **[2025-05-29]** - Analysts discussing performance and outlook in the context of industry trends and global economic factors.
*   **[2025-05-30]** -  Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-26]** - Market experts highlighting both risks and opportunities, advising investors to monitor news.

**Analysis:** The news indicates that Natera is currently experiencing significant developments and market attention. Increased volatility suggests that investors should be prepared for potential price swings. The mixed commentary from analysts further emphasizes the need for caution.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출        |
| ---------- | ----- | ----------- |
| 2025-05-09 | -0.5  | 0.50 B$     |
| 2024-11-12 | -0.26 | 0.44 B$     |
| 2024-08-09 | -0.3  | 0.41 B$     |
| 2024-05-10 | -0.56 | 0.37 B$     |
| 2025-05-09 | -0.56 | 0.37 B$     |

**Analysis:**

*   The company has consistently reported negative EPS, indicating a lack of profitability.
*   Revenue has generally been increasing over the past quarters, which is a positive sign.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
| ---------- | ------- | ------------- |
| 2025-03-31 | $0.50B  | 63.12%        |
| 2024-12-31 | $0.48B  | 62.94%        |
| 2024-09-30 | $0.44B  | 61.79%        |
| 2024-06-30 | $0.41B  | 58.83%        |
| 2024-03-31 | $0.37B  | 56.72%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE      |
| ---------- | ------- | -------- |
| 2025-03-31 | $1.24B  | -5.40%   |
| 2024-12-31 | $1.20B  | -4.50%   |
| 2024-09-30 | $0.88B  | -3.60%   |
| 2024-06-30 | $0.84B  | -4.48%   |
| 2024-03-31 | $0.79B  | -8.51%   |

**Analysis:**

*   **Revenue:**  Shows consistent growth over the past five quarters, indicating strong top-line performance.
*   **Profit Margin:**  Profit margins are high and expanding, suggesting improving operational efficiency despite the lack of overall profitability.
*   **Equity:** Equity has increased, indicating a strengthening balance sheet.
*   **ROE:**  Negative ROE reflects the ongoing losses.

### 7. Overall Summary

Natera (NTRA) presents a mixed picture. It has a history of significant outperformance versus the S&P 500, but also exhibits high volatility and substantial drawdowns.  Recent price action shows a slight downward trend, and while technical indicators are generally neutral, the hybrid signal advises a cautious buying approach. The company is experiencing significant news and events, contributing to volatility.

Financially, Natera shows strong revenue growth and improving profit margins, which are positive signs. However, the company remains unprofitable (negative EPS and ROE).

**Overall Recommendation:**

Given the high volatility, history of significant drawdowns, and current lack of profitability, a **cautious approach** is warranted. The potential for long-term outperformance is present, but investors should be aware of the risks. Monitor news and company announcements closely. The hybrid signal's advice to hold a cash reserve and buy cautiously seems prudent in the current environment. Long-term investors might consider a gradual accumulation strategy, but should be prepared to weather potential volatility.
